Friday, 08 Jan 2021 05:49 PM MYT
BY IDA LIM
Science, Technology and Innovation Minister Khairy Jamaluddin speaks during the launch of the Malaysia Grand Challenge in Putrajaya January 8, 2021. Picture by Shafwan Zaidon
Subscribe to our Telegram channel for the latest updates on news you need to know.
KUALA LUMPUR, Jan 8 Malaysia will be able to use the Pfizer vaccine for Covid-19 upon the expected arrival of its first batch in the country next month, following a conditional approval for the vaccine by a government regulator.
Minister Khairy Jamaluddin today announced on Twitter that the National Pharmaceutical Regulatory Agency (NPRA) has given its conditional registration for the vaccine, noting that this information was conveyed to him by Health director-general Tan Sri Dr Noor Hisham Abdullah.
PETALING JAYA: The Health Ministry's National Pharmaceutical Regulatory Agency (NPRA) has given conditional registration for the Pfizer-BioNTech Covid-19 vaccine, says Khairy Jamaluddin.
KUALA LUMPUR – Conditional registration for the COVID-19 vaccine produced by Pfizer company, Comirnaty Concentrate for Dispersion, has been approved for use in Malaysia, said Health director-general Tan Sri Dr Noor Hisham Abdullah.
Dr Noor Hisham, through his official Twitter and Facebook posts, said the matter was approved by the 352nd Malaysia Drug Control Authority (PBKD) Meeting which convened today.
Advertisement
“Even so, the company still needs to submit some important data within the allotted time before it is allowed to be used,” he said.
Earlier, Minister of Science, Technology and Innovation Khairy Jamaluddin through his official Twitter expressed his congratulations to the National Pharmaceutical Regulatory Agency (NPRA) on the decision for conditional registration for the COVID-19 vaccine from Pfizer.
KUALA LUMPUR: Former 1Malaysia Development Bhd (1MDB) chief executive officer Mohd Hazem Abdul Rahman (pic) told the High Court he would have refused the position in the company if he had known that money was embezzled from its funds.